3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
3
Phase 3
1
Status
Active not recruiting
3
Not yet recruiting
1
Sponsor Class
INDUSTRY
4
Study Type
Interventional
4
Sponsor
Cancer Type
Thoracic
4
Gastrointestinal
3
Conditions
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
3
Colorectal Neoplasms
3
Neoplasm Metastasis
1
Interventions
Carboplatin
121
pembrolizumab
119
Pemetrexed
102
Cisplatin
76
Paclitaxel
56
osimertinib
52
Nivolumab
50
Docetaxel
50
durvalumab
47
Specimen Handling
37
Gemcitabine
34
Magnetic Resonance Spectroscopy
33
Radiosurgery
27
Cetuximab
26
130-nm albumin-bound paclitaxel
26
atezolizumab
25
Radiotherapy
20
Ipilimumab
19
Drug Therapy
19
Bevacizumab
19
cemiplimab
17
amivantamab
17
Taxes
16
Ramucirumab
13
alectinib
12
tislelizumab
11
lazertinib
11
Leucovorin
11
Fluorouracil
11
Radiation
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Carcinoma, Non-Small-Cell Lung
×
JDQ443
×
90 days
×
Clear all
NCT05132075
2026-06-02
KontRASt-02
Novartis
Phase 3
Active not recruiting
95 enrolled
NCT05358249
2026-04-14
KontRASt-03
Novartis
Phase 1/2
Active not recruiting
74 enrolled
NCT07468071
2026-04-02
KontRASt-R
Novartis
Phase 1/2
Not yet recruiting
40 enrolled
NCT04699188
2026-03-18
KontRASt-01
Novartis
Phase 1/2
Active not recruiting
344 enrolled